The observed modulation of TS and TP expression prompted us to investigate if, consequently, HDACi (particularly VPA) might increase the sensitivity of breast cancer cells to fluoropyrimidines such as 5′-DFUR and capecitabine. This evidence concerns the gene TYMS and breast cancer.